Topical Corticosteroids Industry 2018 Increasing Research and Development to US$ 4,440.38 Million by 2024

Global Topical Corticosteroids Market By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Brands, Purchase Mode (OTC-Based, Prescription-Based), Application, Medication Type, Potency Class, End User (Hospital, Dermatology Clinics, Homecare, Others), Distribution Channel, Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) and Forecast to 2024.

Avail 10% instant discount on this report mail us @ sopan.gedam@databridgemarketresearch.com

Global Topical Corticosteroids Market is expected to reach USD 4,440.38 million by 2024, from USD 2,828.36 million in 2016 growing at a CAGR of 5.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Free Sample Copy of this Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-corticosteroids-market

Key Points:

Global topical corticosteroids market is dominated by LEO Pharma, followed by Glaxosmithkline Plc and Pfizer Inc.

Fludroxycortide segment is expected to dominate the global topical corticosteroids market.

The topical corticosteroids market in the global region is leading in North America, Asia-Pacific, and Europe. North America accounts for the highest market share in this region.

Key Drivers:

Global topical corticosteroids market is growing with the increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market.

Order a copy of Topical Corticosteroids Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-corticosteroids-market

Market Segmentation:

The global topical corticosteroids market is segmented on the basis of molecule name, brands, purchase mode, application, medication type, potency class, end user, distribution channel.

On the basis of molecule name, global topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others. In 2017, Fludroxycortide is expected to dominate the Global topical corticosteroids market with 26.2% market share and is expected to reach USD 229.42 million by 2024, growing at a CAGR of 7.2% in the forecast period 2017 to 2024.

On the basis of purchase mode, global topical corticosteroids market is segmented into segmented into OTC-based and prescription-based. In 2017, the prescription based market segment is expected to account for the largest share of 72.1% of the global topical corticosteroids market, by purchase mode. This segment is expected to grow at the highest CAGR of 6.1% in the forecast period 2017 to 2024.

The global topical corticosteroids market, on the basis of brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.

On the basis of application, global topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, the psoriasis is one of the dominating sectors of global topical corticosteroids market with 40.5% market share, growing at the highest CAGR 6.5% in the forecast period 2017 to 2024.

The global topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments is expected to dominate the global topical corticosteroids market with 31.2% market share and is expected to reach USD 1,344.11 million by 2024, with a CAGR of 5.4% in the forecast period 2017 to 2024.

However lotions is expected to grow at the highest CAGR of 7.1% in the forecast period, to reach USD 510.50 million by 2024 from USD 294.87 million in 2016 in the forecast period 2017 to 2024.

The Global topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, the moderate potency class market segment is expected to account for the largest share of 41.0% of the global topical corticosteroids market, by potency class. This segment is expected to grow at the highest CAGR of 6.4% in the forecast period 2017 to 2024.

The global topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, the dermatology clinics market segment is expected to account for the largest share of 43.5% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.6% in the forecast period 2017 to 2024.

The Global topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, the pharmacies stores market segment is expected to account for the largest share of 46.3% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.5% in the forecast period 2017 to 2024.

Read more about the Global Topical Corticosteroids Market Report @ http://databridgemarketresearch.com/reports/global-topical-corticosteroids-market/

Key Topics Mentioned:

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL TOPICAL CORTICOSTEROIDS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION
3.1.2. GROWING NUMBER OF GERIATRIC POPULATION
3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS
3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT
3.1.5. NEW PRODUCT LAUNCHES BY KEY PLAYERS

3.2. RESTRAINTS

3.2.1. EXPIRY OF PATENT FOR DRUGS
3.2.2. WEAK REIMBURSEMENT POLICIES
3.2.3. STRINGENT REGULATORY POLICIES

3.3. OPPORTUNITIES

3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS
3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET
3.3.3. INCREASING MERGERS AND ACQUISITIONS

3.4. CHALLENGES

3.4.1. PRICING PRESSURE BY GOVERNMENT
3.4.2. SIDE EFFECTS OF TOPICAL CORTICOSTEROIDS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME

6.1. OVERVIEW
6.2. FLUDROXYCORTIDE
6.3. TRIAMCINOLONE ACETONIDE
6.4. FLUOCINOLONE ACETONIDE
6.5. ANTISEPTICS
6.6. BETAMETHASONE
6.7. CLOBETASONE PROPIONATE
6.8. CLOBETASONE BUTYRATE
6.9. HALOBETASONE
6.10. MOMETASONE
6.11. OTHERS

7. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS

7.1. OVERVIEW

7.2. ULTRA HIGH

7.2.1. CLOBETASOL PROPIONATE
7.2.2. DIFLORASONE DIACETATE
7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL

7.3. HIGH

7.3.1. AMCINONIDE
7.3.2. BETAMETHASONE DIPROPIONATE
7.3.3. DESOXIMETASONE
7.3.4. FLUOCINONIDE
7.3.5. OTHERS

7.4. MODERATE

7.4.1. DESOXIMETASONE
7.4.2. FLUOCINOLONE ACETONIDE
7.4.3. FLUDROXYCORTIDE
7.4.4. HYDROCORTISONE VALERATE
7.4.5. TRIAMCINOLONE ACETONIDE
7.4.6. CLOBETASONE BUTYRATE
7.4.7. OTHERS

7.5. MILD

7.5.1. HYDROCORTISONE
7.5.2. HYDROCORTISONE ACETATE
7.5.3. BETAMETHASONE VALERATE
7.5.4. DESONIDE
7.5.5. FLUOCINOLONE ACETONIDE
7.5.6. OTHERS

8. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. ACNE
8.3. DERMATITIS
8.4. PSORIASIS
8.5. SKIN INFECTION
8.6. HYPERPIGMENTATION
8.7. MELASMA
8.8. OTHERS

9. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE

9.1. OVERVIEW
9.2. OINTMENTS
9.3. CREAMS
9.4. LIQUID & SOLUTIONS
9.5. LOTIONS
9.6. GEL
9.7. OILS
9.8. PASTES
9.9. SPRAYS
9.10. OTHERS

10. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER

10.1. OVERVIEW
10.2. HOSPITAL
10.3. DERMATOLOGY CLINICS
10.4. HOMECARE
10.5. OTHERS

11. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL

11.1. OVERVIEW
11.2. HOSPITAL PHARMACIES
11.3. PHARMACY STORES
11.4. ONLINE PHARMACIES
11.5. OTHERS

12. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE

12.1. OVERVIEW
12.2. OVER THE COUNTER (OTC) BASED
12.3. PRESCRIPTION BASED

13. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS

13.1. OVERVIEW
13.2. BETNOVATE
13.3. BETNOVATE N
13.4. PANDERM PLUS
13.5. LOBATE
13.6. COSVATE G
13.7. CLOP G
13.8. TENOVATE GN
13.9. LOBATE GM
13.10. ULTIDERM
13.11. FLUTIVATE
13.12. FEXIN
13.13. MOMATE
13.14. CANDIDERM
13.15. OTHERS

14. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY

14.1. OVERVIEW

14.2. NORTH AMERICA

14.2.1. U.S.
14.2.2. CANADA
14.2.3. MEXICO

14.3. EUROPE

14.3.1. GERMANY
14.3.2. FRANCE
14.3.3. U.K.
14.3.4. ITALY
14.3.5. SPAIN
14.3.6. RUSSIA
14.3.7. TURKEY
14.3.8. BELGIUM
14.3.9. NETHERLANDS
14.3.10. SWITZERLAND
14.3.11. REST OF EUROPE

14.4. ASIA-PACIFIC

14.4.1. JAPAN
14.4.2. CHINA
14.4.3. INDIA
14.4.4. SOUTH KOREA
14.4.5. AUSTRALIA
14.4.6. SINGAPORE
14.4.7. THAILAND
14.4.8. MALAYSIA
14.4.9. INDONESIA
14.4.10. PHILIPPINES
14.4.11. REST OF ASIA PACIFIC

14.5. SOUTH AMERICA

14.5.1. BRAZIL
14.5.2. REST OF SOUTH AMERICA
14.6. MIDDLE EAST AND AFRICA
14.6.1. SOUTH AFRICA
14.6.2. REST OF MIDDLE EAST AND AFRICA

15. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE

15.1. COMPANY SHARE ANALYSIS: GLOBAL
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

16. COMPANY PROFILES

16.1. GLAXOSMITHKLINE PLC.

16.1.1. COMPANY OVERVIEW
16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS
16.1.3. PRODUCT PORTFOLIO
16.1.4. RECENT DEVELOPMENTS

16.2. MERCK & CO. INC.

16.2.1. COMPANY OVERVIEW
16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS

16.3. LEO PHARMA

16.3.1. COMPANY OVERVIEW
16.3.2. LEO PHARMA: REVENUE ANALYSIS
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS

16.4. ALMIRALL S.A.

16.4.1. COMPANY OVERVIEW
16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT
16.4.3. PRODUCT PORTFOLIO
16.4.4. RECENT DEVELOPMENTS

16.5. VALEANT PHARMACEUTICALS INTERNATIONAL

16.5.1. COMPANY OVERVIEW
16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS
16.5.3. PRODUCT PORTFOLIO
16.5.4. RECENT DEVELOPMENTS

16.6. ZYLERA PHARMACEUTICALS

16.6.1. COMPANY OVERVIEW
16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS

16.7. SANDOZ INTERNATIONAL GMBH

16.7.1. COMPANY OVERVIEW
16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS

16.8. PFIZER INC.

16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC.: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS

16.9. SANOFI S.A.

16.9.1. COMPANY OVERVIEW
16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS

16.10. ASTRAZENECA

16.10.1. COMPANY OVERVIEW
16.10.2. ASTRAZENECA: REVENUE ANALYSIS
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS

Related Report

Global Biomarkers Market – Industry Trends and Forecast to 2024

Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cancer, Cardiovascular, Immunological), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-biomarkers-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.